December 3, 2016  |  Announcements, Education, Publications  |  By  |  0 Comments

ASH Preview – Don’t Miss These Presentations


Leaders in the field are utilizing the Cytobank Platform to discover more and are presenting these findings at American Society of Hematology’s 2016 Meeting this weekend, one of the most important clinical meetings world wide, driven by explosive growth in immunotherapy related research.

Below, please find information on some of the innovative research utilizing Cytobank at ASH and follow the hashtag #MadewithCytobank on Twitter for alerts.

Saturday, December 3rd:

7:45 AM:
32 Targeting of JAK/STAT Signaling to Reverse Stroma-Induced Cytoprotection Against BCL2 Antagonist Venetoclax in Acute Myeloid Leukemia
Riikka Karjalainen
Institute for Molecular Medicine Finland (FIMM)
University of Helsinki

8:15 AM:
28 Calvariae-Resident Osteomacs That Are Phenotypically and Functionally Distinct from Marrow-Derived Macrophages Interact with Megakaryocytes to Regulate Hematopoietic Stem Cell Function
Safa Mohamad
Indiana University, Dept. of Microbiology & Immunology

5:30-7:30 PM:
1339 Src-like Adaptor Protein Promotes the CD103+ dendritic Cell Homeostasis in the Lung
Namit Sharma
Hospital for Sick Children, Program in Cell Biology

Sunday, December 4th:
8:15 AM
280 BCL-2, a Therapeutic Target for High Risk Hypodiploid B-Cell Acute Lymphoblastic Leukemia
Ernesto Diaz-Flores
Dept. of Pediatrics and the Comprehensive Cancer Center, University of California, San Francisco

8:30 AM:
275 Bacteremia, Not Coagulation Proteases Contribute to In Vivo Complement Activation in Sepsis
Ravi Shankar Keshari
Cardiovascular Biology Research Program
Oklahoma Medical Research Foundation

5:00 PM
465 Combining In Situ Vaccination with Immune Checkpoint Blockade Induces Long-Term Regression of Lymphoma Tumors
Linda Hammerich
Icahn School of Medicine at Mount Sinai

6:00 PM-8:00 PM:
2677 Human Placenta-Derived Stromal Cells Rescue Mice from Radiation-Induced Bone Marrow Failure: A Cytof-Based Mechanistic Analysis
Hoshea Allen
Pluristem Therapeutics

2947 Examining the Heterogeneity of Follicular Lymphoma By Multi-Parameter Flow Cyotmetry in Previously Untreated Patients
Debra Czerwinski
Division of Oncology, Department of Medicine
Stanford University School of Medicine

Sunday, December 4th:

6:00-8:00 PM:
4278 Identification of Functionally Primitive and Immunophenotypically Distinct Subpopulations in Secondary Acute Myeloid Leukemia By Mass Cytometry
Shovik Bandyopadhyay
Division of Hematology
Washington University School of Medicine

4277 Mass Cytometry Analysis of Dysregulated Cytokine Production and Intracellular Signaling in Myelofibrosis
Steve Oh
Division of Hematology
Washington University School of Medicine

636 Mass Cytometry Reveals PD1 Upregulation Is an Early Step in MDS Disease Progression
Thomas Coats
Department of Haematological Medicine
King’s College London

4303 Expression of S100A9 in Bone Marrow Cells Differentiates Refractory Cytopenia with Multilineage Dysplasia (RCMD) from Refractory Anemia with Excess Blasts (RAEB) and Acute Myeloid Leukemia (AML)
Brent Ferrell
Vanderbilt University Medical Center

4572 Systems Immune Monitoring with Mass Cytometry Characterizes Altered Peripheral Immune Cell Environments in Patients with Chronic Graft Versus Host Disease
Hannah Polikowsky
Cytobank and Vanderbilt University